FOCUS Healthcare Team Members Close 8 Medical Practice Transactions in 18 Months
Members of the FOCUS Healthcare team announced eight completed transactions for a combined 15 clinical businesses in the last 18 months.
Members of the FOCUS Healthcare team announced eight completed transactions for a combined 15 clinical businesses in the last 18 months.
FOCUS Investment Banking (“FOCUS”), a Washington DC-based investment bank, represented Clinart, a regional CRO (Contract Research Organization) located in Dubai, in its acquisition by CTI, Clinical Trial and Consulting Services, an international CRO headquartered in Cincinnati, Ohio.
A comprehensive view of ophthalmology's recovery from the pandemic shutdown. We review changes in elective surgery, the emerging investor interest in retina practices, private equity acquisition activity, geographic development, and changes to acquisition practice size. As the COVID-19 fog begins to clear, we see significant near-term promise and a potential return to record deal levels.
After seven strong years, private equity investment in dermatology has been in decline since 2019. Now, elective procedure bans and shelter-in-place orders have practice owners wondering if the opportunity to sell has passed. This paper examines the differing views on pe-backed consolidation, key performance indicators, investor activity, and saturation by geography and practice size. We see several positive factors for our current and potential clients within a coming private equity player restructuring.
Eight years of consolidation activity has resulted in a wide spread of PE-backed practices across the United States.
Based on our detailed tracking and analysis, the dermatology market is only 11.5% consolidated as of this publication.
Two key factors provide a view of current and future consolidation speed.
The number of private equity firms investing in gastroenterology practices and surgery centers doubled in 2019. As of the end of 2019, six PE firms were actively investing in the space with three new firms entering in the last three quarters of 2019.
As of the end of 2019, there were 25 private equity firms actively investing in ophthalmology practices and surgery centers. It is among the most active physician practice consolidations currently taking place in the United States.
Our recently published white paper examined all core aspects of private equity's investment in ophthalmology practices and surgery centers from 2012 – 2019.